Polydyne clarifloc c-6286

The University of New Mexico (UNM) Purchasing Department is pursuing a sole source procurement for Light Adjustable Lens (LAL) intraocular lenses from RxSight, specifically for the Ophthalmology Department. This medical technology acquisition is focused on obtaining a unique intraocular lens used during cataract surgery that enables post-surgical lens power adjustments through precise UV light treatments. The procurement is a critical medical technology purchase with specific requirements for a lens that can fine-tune patient prescriptions after surgical intervention. The contract is structured for a three-year term with potential renewals, consistent with New Mexico Procurement Code. The procurement opportunity is located in Valencia County and has a posted date of October 26, 2025, with a response deadline of November 26, 2025. UNM conducted a comprehensive vendor investigation, examining alternatives from Alcon, Bausch & Lomb, and Johnson & Johnson, ultimately determining that RxSight is the sole manufacturer offering post-surgical lens adjustment capabilities.

The procurement appears to have no specific set-aside designations or restrictions on responding organizations. The contract value is established at $100,000, representing a targeted medical technology investment. RxSight is positioned as the exclusive vendor for this procurement, with no incumbent vendors noted for replacement. The technology represents an advanced medical solution that provides patients the potential for optimal glasses-free vision by correcting residual refractive errors that traditional, non-adjustable lenses cannot address. The procurement methodology follows a sole source approach, justified by RxSight's unique technological capabilities in producing adjustable intraocular lenses. The procurement is specifically designed to introduce a new standard of care in ophthalmological surgical interventions, with a focus on precision and post-surgical vision optimization.